Mario Colucci Selected Research

Adenosine (Adenocard)

1/2009

Adenosine A1 and A3 receptor agonists inhibit nonadrenergic, noncholinergic relaxations in the guinea pig isolated trachea.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mario Colucci Research Topics

Disease

13	Thrombosis (Thrombus) 01/2021 - 08/2002
6	Sepsis (Septicemia) 01/2020 - 08/2010
5	Inflammation (Inflammations) 04/2020 - 08/2010
5	Hemorrhage 01/2020 - 07/2003
5	Thrombophilia 05/2017 - 12/2003
4	Venous Thromboembolism 11/2022 - 08/2010
3	Disseminated Intravascular Coagulation 09/2015 - 08/2010
2	Atrial Fibrillation 11/2022 - 02/2016
2	Hemophilia A (Haemophilia) 07/2020 - 01/2020
2	Multiple Organ Failure (MODS) 03/2012 - 08/2010
2	Activated Protein C Resistance (APC Resistance) 04/2006 - 12/2003
2	Hyperprothrombinemia 04/2006 - 03/2004
1	Hypoxia (Hypoxemia) 01/2021
1	Infections 01/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020
1	Non-alcoholic Fatty Liver Disease 01/2020
1	Septic Shock (Toxic Shock Syndrome) 01/2018
1	Thrombocytopenia (Thrombopenia) 01/2018
1	Pituitary ACTH Hypersecretion 05/2017
1	Stroke (Strokes) 09/2012
1	Edema (Dropsy) 09/2012
1	Brain Ischemia (Cerebral Ischemia) 09/2012
1	Constipation 08/2012
1	Obesity 08/2012
1	Binge Drinking 02/2012
1	Alcoholism (Alcohol Abuse) 02/2012
1	Necrosis 08/2010
1	Respiratory Hypersensitivity 01/2009
1	Fibrosis (Cirrhosis) 07/2003

Drug/Important Bio-Agent (IBA)

8	Thrombin FDA Link 11/2022 - 07/2003
6	Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA 01/2021 - 07/2003
4	Proteins (Proteins, Gene)FDA Link 04/2020 - 08/2010
3	AnticoagulantsIBA 11/2022 - 05/2017
3	FibrinIBA 01/2020 - 04/2006
3	Heparin (Liquaemin)FDA LinkGeneric 02/2016 - 08/2002
3	Histones (Histone)IBA 02/2016 - 08/2010
3	Antifibrinolytic Agents (Antifibrinolytics)IBA 03/2004 - 07/2003
2	apixabanIBA 11/2022 - 02/2016
2	Dabigatran FDA Link 11/2022 - 02/2016
2	RivaroxabanIBA 11/2022 - 02/2016
2	Plasminogen Activators (Plasminogen Activator)IBA 01/2021 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 04/2020 - 02/2016
2	EnzymesIBA 01/2020 - 08/2010
2	Factor VIII (Coagulation Factor VIII)IBA 01/2020 - 05/2017
2	fibrin fragment D (D-dimer)IBA 01/2020 - 01/2019
2	PlasminogenIBA 02/2016 - 04/2006
2	Dacarbazine (DIC)FDA LinkGeneric 03/2012 - 08/2010
2	Prothrombin (Factor II)IBA 04/2006 - 03/2004
2	CarboxypeptidasesIBA 03/2004 - 07/2003
1	edoxabanIBA 11/2022
1	Angiotensin IIIBA 01/2021
1	CytokinesIBA 01/2021
1	Thromboplastin (Tissue Factor)IBA 01/2021
1	Immunoglobulin G (IgG)IBA 07/2020
1	Choline (Choline Chloride)IBA 01/2020
1	CurcuminIBA 01/2020
1	Fibrinolysin FDA Link 01/2020
1	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2020
1	SilymarinIBA 01/2020
1	Tocopherols (Tocopherol)IBA 01/2020
1	AlbuminsIBA 01/2018
1	ThrombomodulinIBA 05/2017
1	GlucocorticoidsIBA 05/2017
1	AntithrombinsIBA 02/2016
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 04/2014
1	Glyburide (Glibenclamide)FDA LinkGeneric 09/2012
1	Sulfonylurea ReceptorsIBA 09/2012
1	Complement System Proteins (Complement)IBA 09/2012
1	Tissue Plasminogen Activator (Alteplase)FDA Link 09/2012
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 09/2012
1	Oxidopamine (6 Hydroxydopamine)IBA 08/2012
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 08/2012
1	Plasminogen Activator Inhibitor 1IBA 08/2012
1	NexusIBA 03/2012
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 03/2012
1	HMGB ProteinsIBA 03/2012
1	Biomarkers (Surrogate Marker)IBA 02/2012
1	ethyl glucuronideIBA 02/2012
1	Nuclear Proteins (Protein, Nuclear)IBA 08/2010
1	Adenosine (Adenocard)FDA LinkGeneric 01/2009
1	melagatranIBA 12/2007
1	Factor V (Coagulation Factor V)IBA 12/2003

Therapy/Procedure

1	Injections 09/2012
1	Thrombolytic Therapy 03/2012